These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
108 related articles for article (PubMed ID: 36444746)
1. Amphiphilic phosphorous dendron micelles co-deliver microRNA inhibitor and doxorubicin for augmented triple negative breast cancer therapy. Chen L; Zhan M; Li J; Cao L; Sun H; Laurent R; Mignani S; Caminade AM; Majoral JP; Shi X J Mater Chem B; 2023 Jun; 11(24):5483-5493. PubMed ID: 36444746 [TBL] [Abstract][Full Text] [Related]
2. Engineered Stable Bioactive Per Se Amphiphilic Phosphorus Dendron Nanomicelles as a Highly Efficient Drug Delivery System To Take Down Breast Cancer In Vivo. Chen L; Cao L; Zhan M; Li J; Wang D; Laurent R; Mignani S; Caminade AM; Majoral JP; Shi X Biomacromolecules; 2022 Jul; 23(7):2827-2837. PubMed ID: 35694854 [TBL] [Abstract][Full Text] [Related]
3. Sequential co-delivery of miR-21 inhibitor followed by burst release doxorubicin using NIR-responsive hollow gold nanoparticle to enhance anticancer efficacy. Ren Y; Wang R; Gao L; Li K; Zhou X; Guo H; Liu C; Han D; Tian J; Ye Q; Hu YT; Sun D; Yuan X; Zhang N J Control Release; 2016 Apr; 228():74-86. PubMed ID: 26956593 [TBL] [Abstract][Full Text] [Related]
4. Phosphorous Dendron Micelles as a Nanomedicine Platform for Cooperative Tumor Chemoimmunotherapy via Synergistic Modulation of Immune Cells. Zhan M; Qiu J; Fan Y; Chen L; Guo Y; Wang Z; Li J; Majoral JP; Shi X Adv Mater; 2023 Jan; 35(3):e2208277. PubMed ID: 36300810 [TBL] [Abstract][Full Text] [Related]
5. Calcium phosphate-polymeric nanoparticle system for co-delivery of microRNA-21 inhibitor and doxorubicin. Sriram V; Lee JY Colloids Surf B Biointerfaces; 2021 Dec; 208():112061. PubMed ID: 34492599 [TBL] [Abstract][Full Text] [Related]
6. Star-branched amphiphilic PLA-b-PDMAEMA copolymers for co-delivery of miR-21 inhibitor and doxorubicin to treat glioma. Qian X; Long L; Shi Z; Liu C; Qiu M; Sheng J; Pu P; Yuan X; Ren Y; Kang C Biomaterials; 2014 Feb; 35(7):2322-35. PubMed ID: 24332459 [TBL] [Abstract][Full Text] [Related]
7. Peptide-modified bioresponsive chondroitin sulfate micelles for targeted doxorubicin delivery in triple-negative breast cancer. Yu J; Wang L; Ling Y; Xiao X; Gong J; Jin H; Xu J; Chen P; Xie X; Zhang L Colloids Surf B Biointerfaces; 2023 Jul; 227():113381. PubMed ID: 37257299 [TBL] [Abstract][Full Text] [Related]
8. Cationic phosphorus dendron nanomicelles deliver microRNA mimics and microRNA inhibitors for enhanced anti-inflammatory therapy of acute lung injury. Li J; Chen L; Sun H; Zhan M; Laurent R; Mignani S; Majoral JP; Shen M; Shi X Biomater Sci; 2023 Feb; 11(4):1530-1539. PubMed ID: 36607143 [TBL] [Abstract][Full Text] [Related]
9. A Multifunctional, Highly Biocompatible, and Double-Triggering Caramelized Nanotheranostic System Loaded with Fe Wang F; Li N; Wang W; Ma L; Sun Y; Wang H; Zhan J; Yu D Int J Nanomedicine; 2023; 18():881-897. PubMed ID: 36844435 [TBL] [Abstract][Full Text] [Related]
10. Facile Synthesis of Amphiphilic Fluorescent Phosphorus Dendron-Based Micelles as Antiproliferative Agents: First Investigations. Qiu J; Chen L; Zhan M; Laurent R; Bignon J; Mignani S; Shi X; Caminade AM; Majoral JP Bioconjug Chem; 2021 Feb; 32(2):339-349. PubMed ID: 33522223 [TBL] [Abstract][Full Text] [Related]
11. Biocompatible cationic pullulan-g-desoxycholic acid-g-PEI micelles used to co-deliver drug and gene for cancer therapy. Chen L; Ji F; Bao Y; Xia J; Guo L; Wang J; Li Y Mater Sci Eng C Mater Biol Appl; 2017 Jan; 70(Pt 1):418-429. PubMed ID: 27770912 [TBL] [Abstract][Full Text] [Related]
12. Hyaluronic acid-chitosan nanoparticles for co-delivery of MiR-34a and doxorubicin in therapy against triple negative breast cancer. Deng X; Cao M; Zhang J; Hu K; Yin Z; Zhou Z; Xiao X; Yang Y; Sheng W; Wu Y; Zeng Y Biomaterials; 2014 May; 35(14):4333-44. PubMed ID: 24565525 [TBL] [Abstract][Full Text] [Related]
13. Ultrasound-enhanced theranostics of orthotopic breast cancer through a multifunctional core-shell tecto dendrimer-based nanomedicine platform. Gong J; Song C; Li G; Guo Y; Wang Z; Guo H; Xia J; Tao Y; Shi Q; Shi X; Shen M Biomater Sci; 2023 Jun; 11(12):4385-4396. PubMed ID: 37158209 [TBL] [Abstract][Full Text] [Related]
14. A Comparative Study of Cellular Uptake and Subcellular Localization of Doxorubicin Loaded in Self-Assemblies of Amphiphilic Copolymers with Pendant Dendron by MDA-MB-231 Human Breast Cancer Cells. Viswanathan G; Hsu YH; Voon SH; Imae T; Siriviriyanun A; Lee HB; Kiew LV; Chung LY; Yusa S Macromol Biosci; 2016 Jun; 16(6):882-95. PubMed ID: 26900760 [TBL] [Abstract][Full Text] [Related]
15. mPEGylated solanesol micelles as redox-responsive nanocarriers with synergistic anticancer effect. Qin B; Liu L; Wu X; Liang F; Hou T; Pan Y; Song S Acta Biomater; 2017 Dec; 64():211-222. PubMed ID: 28963017 [TBL] [Abstract][Full Text] [Related]
16. Efficient co-delivery of microRNA 21 inhibitor and doxorubicin to cancer cells using core-shell tecto dendrimers formed via supramolecular host-guest assembly. Song C; Xiao Y; Ouyang Z; Shen M; Shi X J Mater Chem B; 2020 Apr; 8(14):2768-2774. PubMed ID: 32154812 [TBL] [Abstract][Full Text] [Related]
17. pH-Sensitive Dextran-Based Micelles from Copper-Free Click Reaction for Antitumor Drug Delivery. Liu P; Huang P; Kang ET Langmuir; 2021 Nov; 37(44):12990-12999. PubMed ID: 34714094 [TBL] [Abstract][Full Text] [Related]
18. Hyaluronic acid-coated PEI-PLGA nanoparticles mediated co-delivery of doxorubicin and miR-542-3p for triple negative breast cancer therapy. Wang S; Zhang J; Wang Y; Chen M Nanomedicine; 2016 Feb; 12(2):411-20. PubMed ID: 26711968 [TBL] [Abstract][Full Text] [Related]
19. Doxorubicin-Loaded Micelle Targeting MUC1: A Potential Therapeutic for MUC1 Triple Negative Breast Cancer Treatment. Khondee S; Chittasupho C; Tima S; Anuchapreeda S Curr Drug Deliv; 2018; 15(3):406-416. PubMed ID: 28707580 [TBL] [Abstract][Full Text] [Related]
20. Polymeric Hybrid Nanomicelles for Cancer Theranostics: An Efficient and Precise Anticancer Strategy for the Codelivery of Doxorubicin/miR-34a and Magnetic Resonance Imaging. Xie X; Chen Y; Chen Z; Feng Y; Wang J; Li T; Li S; Qin X; Wu C; Zheng C; Zhu J; You F; Liu Y; Yang H ACS Appl Mater Interfaces; 2019 Nov; 11(47):43865-43878. PubMed ID: 31684723 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]